Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema

Ozurdex MEAD Study Group, Richard Babington Newsom

Research output: Contribution to journalArticlepeer-review

217 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema'. Together they form a unique fingerprint.

INIS

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science